Backs FY24 revenue view $2.45B-$2.48B, consensus $2.46B. The company said, “The Company reaffirms its full year 2024 revenue guidance range of $2.450 billion to $2.475 billion and fully diluted non-GAAP earnings per share range between $2.68 to $2.70.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on GMED:
- Globus Medical Reports Fourth Quarter and Full Year 2023 Results
- Globus Medical Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
- Globus Medical Promotes Keith Pfeil to COO and CFO
- Globus Medical promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer
- Globus Medical promotes Keith Pfeil as COO and Chief Financial Officer
